Exploring Ugi-Azide Four-Component Reaction Products for Broad-Spectrum Influenza Antivirals with a High Genetic Barrier to Drug Resistance

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 2045-2322

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Exploring Ugi-Azide Four-Component Reaction Products for Broad-Spectrum Influenza Antivirals with a High Genetic Barrier to Drug Resistance ; volume:8 ; number:1 ; day:15 ; month:3 ; year:2018 ; pages:1-14 ; date:12.2018
Scientific reports ; 8, Heft 1 (15.3.2018), 1-14, 12.2018

Classification: Medizin, Gesundheit

Creator: Zhang, Jiantao

Contributor: Hu, Yanmei
Foley, Christopher
Wang, Yuanxiang
Musharrafieh, Rami
Xu, Shuting
Zhang, Yongtao
Ma, Chunlong
Hulme, Christopher
Wang, Jun
SpringerLink (Online service)

DOI: 10.1038/s41598-018-22875-9

URN: urn:nbn:de:1111-201805145222

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:48 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Zhang, Jiantao
Hu, Yanmei
Foley, Christopher
Wang, Yuanxiang
Musharrafieh, Rami
Xu, Shuting
Zhang, Yongtao
Ma, Chunlong
Hulme, Christopher
Wang, Jun
SpringerLink (Online service)

Other Objects (12)

Advanced molecular tweezers as broad-spectrum antivirals

Expanding horizons of iminosugars as broad-spectrum anti-virals: mechanism, efficacy and novel developments

A painful lesson from the COVID-19 pandemic: the need for broad-spectrum, host-directed antivirals

Macromolecular viral entry inhibitors as broad-spectrum first-line antivirals with activity against SARS-CoV-2

Macromolecular Viral Entry Inhibitors as Broad‐Spectrum First‐Line Antivirals with Activity against SARS‐CoV‐2

Enantioselective Ugi and Ugi-azide reactions catalyzed by anionic stereogenic-at-cobalt(III) complexes

Broad-spectrum inflammasome inhibition by thiomuscimol

Two genomic regions of a sodium azide induced rice mutant confer broad-spectrum and durable resistance to blast disease

Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2

Novel quinoline derivatives with broad‐spectrum antiprotozoal activities

Synthetic optimization of cystobactamids as broad-spectrum antibiotics

Correction to: Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2

Advanced molecular tweezers as broad-spectrum antivirals

Expanding horizons of iminosugars as broad-spectrum anti-virals: mechanism, efficacy and novel developments

A painful lesson from the COVID-19 pandemic: the need for broad-spectrum, host-directed antivirals

Macromolecular viral entry inhibitors as broad-spectrum first-line antivirals with activity against SARS-CoV-2

Macromolecular Viral Entry Inhibitors as Broad‐Spectrum First‐Line Antivirals with Activity against SARS‐CoV‐2

Enantioselective Ugi and Ugi-azide reactions catalyzed by anionic stereogenic-at-cobalt(III) complexes

Broad-spectrum inflammasome inhibition by thiomuscimol

Two genomic regions of a sodium azide induced rice mutant confer broad-spectrum and durable resistance to blast disease

Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2

Novel quinoline derivatives with broad‐spectrum antiprotozoal activities

Synthetic optimization of cystobactamids as broad-spectrum antibiotics

Correction to: Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2

Advanced molecular tweezers as broad-spectrum antivirals

Expanding horizons of iminosugars as broad-spectrum anti-virals: mechanism, efficacy and novel developments

A painful lesson from the COVID-19 pandemic: the need for broad-spectrum, host-directed antivirals

Macromolecular viral entry inhibitors as broad-spectrum first-line antivirals with activity against SARS-CoV-2

Macromolecular Viral Entry Inhibitors as Broad‐Spectrum First‐Line Antivirals with Activity against SARS‐CoV‐2

Enantioselective Ugi and Ugi-azide reactions catalyzed by anionic stereogenic-at-cobalt(III) complexes

Broad-spectrum inflammasome inhibition by thiomuscimol

Two genomic regions of a sodium azide induced rice mutant confer broad-spectrum and durable resistance to blast disease

Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2

Novel quinoline derivatives with broad‐spectrum antiprotozoal activities

Synthetic optimization of cystobactamids as broad-spectrum antibiotics

Correction to: Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Exploring Ugi-Azide Four-Component Reaction Products for Broad-Spectrum Influenza Antivirals with a High Genetic Barrier to Drug Resistance

Object Details

References and Relationships

Classification and Topics

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Advanced molecular tweezers as broad-spectrum antivirals

Expanding horizons of iminosugars as broad-spectrum anti-virals: mechanism, efficacy and novel developments

A painful lesson from the COVID-19 pandemic: the need for broad-spectrum, host-directed antivirals

Macromolecular viral entry inhibitors as broad-spectrum first-line antivirals with activity against SARS-CoV-2

Macromolecular Viral Entry Inhibitors as Broad‐Spectrum First‐Line Antivirals with Activity against SARS‐CoV‐2

Enantioselective Ugi and Ugi-azide reactions catalyzed by anionic stereogenic-at-cobalt(III) complexes

Broad-spectrum inflammasome inhibition by thiomuscimol

Two genomic regions of a sodium azide induced rice mutant confer broad-spectrum and durable resistance to blast disease

Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2

Novel quinoline derivatives with broad‐spectrum antiprotozoal activities

Synthetic optimization of cystobactamids as broad-spectrum antibiotics

Correction to: Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2

Advanced molecular tweezers as broad-spectrum antivirals

Expanding horizons of iminosugars as broad-spectrum anti-virals: mechanism, efficacy and novel developments

A painful lesson from the COVID-19 pandemic: the need for broad-spectrum, host-directed antivirals

Macromolecular viral entry inhibitors as broad-spectrum first-line antivirals with activity against SARS-CoV-2

Macromolecular Viral Entry Inhibitors as Broad‐Spectrum First‐Line Antivirals with Activity against SARS‐CoV‐2

Enantioselective Ugi and Ugi-azide reactions catalyzed by anionic stereogenic-at-cobalt(III) complexes

Broad-spectrum inflammasome inhibition by thiomuscimol

Two genomic regions of a sodium azide induced rice mutant confer broad-spectrum and durable resistance to blast disease

Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2

Novel quinoline derivatives with broad‐spectrum antiprotozoal activities

Synthetic optimization of cystobactamids as broad-spectrum antibiotics

Correction to: Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2

Advanced molecular tweezers as broad-spectrum antivirals

Expanding horizons of iminosugars as broad-spectrum anti-virals: mechanism, efficacy and novel developments

A painful lesson from the COVID-19 pandemic: the need for broad-spectrum, host-directed antivirals

Macromolecular viral entry inhibitors as broad-spectrum first-line antivirals with activity against SARS-CoV-2

Macromolecular Viral Entry Inhibitors as Broad‐Spectrum First‐Line Antivirals with Activity against SARS‐CoV‐2

Enantioselective Ugi and Ugi-azide reactions catalyzed by anionic stereogenic-at-cobalt(III) complexes

Broad-spectrum inflammasome inhibition by thiomuscimol

Two genomic regions of a sodium azide induced rice mutant confer broad-spectrum and durable resistance to blast disease

Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2

Novel quinoline derivatives with broad‐spectrum antiprotozoal activities

Synthetic optimization of cystobactamids as broad-spectrum antibiotics

Correction to: Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2

Related objects

Reset password